- Home
- INDI vs IMTX Comparison
INDI vs IMTX Comparison
Compare INDI & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDI
- IMTX
- Stock Information
- Founded
- INDI 2007
- IMTX N/A
- Country
- INDI United States
- IMTX Germany
- Employees
- INDI N/A
- IMTX N/A
- Industry
- INDI Semiconductors
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- INDI Technology
- IMTX Health Care
- Exchange
- INDI Nasdaq
- IMTX Nasdaq
- Market Cap
- INDI 790.2M
- IMTX 865.5M
- IPO Year
- INDI N/A
- IMTX N/A
- Fundamental
- Price
- INDI $4.38
- IMTX $9.39
- Analyst Decision
- INDI Strong Buy
- IMTX Strong Buy
- Analyst Count
- INDI 5
- IMTX 5
- Target Price
- INDI $5.90
- IMTX $15.00
- AVG Volume (30 Days)
- INDI 4.2M
- IMTX 800.4K
- Earning Date
- INDI 11-06-2025
- IMTX 11-17-2025
- Dividend Yield
- INDI N/A
- IMTX N/A
- EPS Growth
- INDI N/A
- IMTX N/A
- EPS
- INDI N/A
- IMTX N/A
- Revenue
- INDI $217,685,000.00
- IMTX $152,823,253.00
- Revenue This Year
- INDI $4.53
- IMTX N/A
- Revenue Next Year
- INDI $31.60
- IMTX N/A
- P/E Ratio
- INDI N/A
- IMTX N/A
- Revenue Growth
- INDI N/A
- IMTX 83.61
- 52 Week Low
- INDI $1.53
- IMTX $3.30
- 52 Week High
- INDI $5.57
- IMTX $11.40
- Technical
- Relative Strength Index (RSI)
- INDI 60.62
- IMTX 79.00
- Support Level
- INDI $3.88
- IMTX $6.90
- Resistance Level
- INDI $4.17
- IMTX $9.25
- Average True Range (ATR)
- INDI 0.23
- IMTX 0.46
- MACD
- INDI 0.06
- IMTX 0.27
- Stochastic Oscillator
- INDI 84.78
- IMTX 95.86
About INDI indie Semiconductor Inc.
Indie Semiconductor Inc is empowering the Autotech revolution with next-generation automotive semiconductors and software platforms. It focuses on edge sensors for Driver Assistance Systems including LiDAR, connected car, user experience, and electrification applications. These technologies represent the core underpinnings of both electric and autonomous vehicles, while the user interfaces transform the in-cabin experience to mirror and seamlessly connect to the mobile platforms. Geographically, the company generates majority of its revenue from Greater China and rest from United States, Europe, South Korea and other regions.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.